Paraneoplastic Cerebellar Degeneration in Ovarian Carcinoma: Case Report with Review of Immune Modulation
Overview
Oncology
Authors
Affiliations
Paraneoplastic cerebellar degeneration (PCD) is a rare nonmetastatic complication of a carcinoma. It is typically mediated by antibodies generated against tumor antigens. These antigens are the same proteins as expressed on Purkinje cells within the cerebellum; immune activation in the central nervous system (CNS) results in the syndrome. A 56-year-old woman with stage IIIC serous ovarian carcinoma diagnosed 3 years prior developed progressive limb ataxia. Serum anti-Yo antibodies were positive, confirming the diagnosis of PCD. Treatment with plasmaphoresis, intravenous immune globulin, and immune modulation with corticosteroids and tacrolimus was unsuccessful. Although the syndrome can be debilitating and treatment options are limited, it may also be an example of a successful host immune response in certain cases.
Therapeutic Plasma Exchange: For Cancer Patients.
Hu Y, Yang H, Fu S, Wu J Cancer Manag Res. 2022; 14:411-425.
PMID: 35140519 PMC: 8818550. DOI: 10.2147/CMAR.S340472.
Lou Y, Xu S, Zhang S, Shu Q, Liu X World J Clin Cases. 2021; 9(17):4423-4432.
PMID: 34141810 PMC: 8173421. DOI: 10.12998/wjcc.v9.i17.4423.
Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review.
Venkatraman A, Opal P Ann Clin Transl Neurol. 2016; 3(8):655-63.
PMID: 27606347 PMC: 4999597. DOI: 10.1002/acn3.328.
Paraneoplastic Neurological Syndrome in Fallopian Tube Cancer.
Maas E, Skoberne T, Werner A, Braun S, Jackisch C Geburtshilfe Frauenheilkd. 2014; 74(10):950-953.
PMID: 25364036 PMC: 4210378. DOI: 10.1055/s-0034-1383041.
Ovarian cancer revealed by paraneoplastic cerebellar degeneration: a case report.
Elomrani F, Ouziane I, Boutayeb S, Bensouda Y, Mrabti H, Errihani H Pan Afr Med J. 2014; 18:2.
PMID: 25360186 PMC: 4212434. DOI: 10.11604/pamj.2014.18.2.2808.